Need help finding what you are looking for?
Contact Us
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1421745
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1421745
Vaccine Contract Manufacturing Market Share, Size, Trends, Industry Analysis Report, By Vaccine Type ; By Application; By Process; By Region; Segment Forecast, 2023- 2032
PUBLISHED:
PAGES: 119 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The global vaccine contract manufacturing market size is expected to reach USD 13.16 billion by 2032, according to a new study by Polaris Market Research. The report "Vaccine Contract Manufacturing Market Share, Size, Trends, Industry Analysis Report, By Vaccine Type (Inactivated Vaccine, DNA Vaccines, Attenuated Vaccine, Toxoid Vaccines, Subunit Vaccines); By Application; By Process; By Region; Segment Forecast, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
Pharmaceutical and biopharmaceutical companies are strategically prioritizing their core competencies to navigate the escalating price pressures. Consequently, there is a growing inclination towards contract manufacturing.
However, vaccine production presents a complex challenge for manufacturers as they strive to guarantee safety, effectiveness, and consistency. The vaccine contract manufacturing market is driven by a diverse range of services encompassing production processes, the establishment and operation of manufacturing facilities, cell line development, fermentation, process refinement, and analytical characterization. These services collectively play a pivotal role in driving the market's substantial growth on a worldwide level.
Vaccination plays an important role in enhancing both human and veterinary health. It not only diminishes reliance on antibiotics but also serves as a potent deterrent against various diseases. The escalating recognition of its manifold advantages, which include safeguarding against severe illnesses and infectious conditions, is fueling the call for widespread immunization initiatives and inoculation programs. In tandem with this, the cognizance of the substantial capital outlay needed for production has prompted major pharmaceutical entities to opt for outsourcing in the realm of vaccine manufacturing.
However, in low-resource countries, the shortage of equipment and proficient labor for vaccine production is a significant factor driving the expansion of the global vaccine contract manufacturing market. Additionally, the introduction of advanced expression systems such as EB66 and GPEx, along with innovative cell culture media platforms, is providing substantial support for market growth. Furthermore, the surging instances of COVID-19 in various nations have prompted vaccine developers to engage in outsourcing agreements with Contract Manufacturing Organizations (CMOs), fostering a positive trajectory for market advancement.
Vaccine Contract Manufacturing Market Report Highlights
The Inactivated Vaccine segment is expected to witness the fastest CAGR during the forecast period on account of better efficiency.
The veterinary segment held a significant share in revenue share in 2022, which is mainly driven by increased utilization of CMOs in the production of animal vaccinations.
In 2022, the downstream segment held the largest market share due to technological advancements and innovation.
In 2022, the North American region held the largest market share, owing to exponential growth in technology and rising R&D investments.
The global key market players include: Fujifilm Diosynth Biotechnologies, IDT Biologika GmbH, KBI Biopharma, Lonza Group, Merck KGaA, and more.
Polaris Market Research has segmented the vaccine contract manufacturing market report based on vaccine type, application, process, and region:
Vaccine Contract Manufacturing, Vaccine Type Outlook (Revenue - USD Billion, 2019 - 2032)
- Inactivated Vaccine
- DNA Vaccines
- Attenuated Vaccine
- Toxoid Vaccines
- Subunit Vaccines
Vaccine Contract Manufacturing, Application Outlook (Revenue - USD Billion, 2019 - 2032)
- Human
- Veterinary
Vaccine Contract Manufacturing, Process Outlook (Revenue - USD Billion, 2019 - 2032)
- Upstream
- Downstream
Vaccine Contract Manufacturing, Regional Outlook (Revenue - USD Billion, 2019 - 2032)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
- Latin America
- Argentina
- Brazil
- Mexico
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
Product Code: PM4069
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Vaccine Contract Manufacturing Market Insights
- 4.1. Vaccine Contract Manufacturing Market - Process Snapshot
- 4.2. Vaccine Contract Manufacturing Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Increased demand for vaccines is projected to spur the product demand
- 4.2.1.2. Biopharmaceutical Advancements
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Complex Regulatory Environment
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Vaccine Contract Manufacturing Market Process Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Vaccine Contract Manufacturing Market, by Vaccine Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
- 5.3. Inactivated Vaccine
- 5.3.1. Global Vaccine Contract Manufacturing Market, by Inactivated Vaccine, by Region, 2019-2032 (USD Billion)
- 5.4. DNA Vaccines
- 5.4.1. Global Vaccine Contract Manufacturing Market, by DNA Vaccines, by Region, 2019-2032 (USD Billion)
- 5.5. Attenuated Vaccine
- 5.5.1. Global Vaccine Contract Manufacturing Market, by Attenuated Vaccine, by Region, 2019-2032 (USD Billion)
- 5.6. Toxoid Vaccines
- 5.6.1. Global Vaccine Contract Manufacturing Market, by Toxoid Vaccines, by Region, 2019-2032 (USD Billion)
- 5.7. Subunit Vaccines
- 5.7.1. Global Vaccine Contract Manufacturing Market, by Subunit Vaccines, by Region, 2019-2032 (USD Billion)
6. Global Vaccine Contract Manufacturing Market, by Application
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
- 6.3. Human
- 6.3.1. Global Vaccine Contract Manufacturing Market, by Human, by Region, 2019-2032 (USD Billion)
- 6.4. Veterinary
- 6.4.1. Global Vaccine Contract Manufacturing Market, by Veterinary, by Region, 2019-2032 (USD Billion)
7. Global Vaccine Contract Manufacturing Market, by Process
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
- 7.3. Upstream
- 7.3.1. Global Vaccine Contract Manufacturing Market, by Upstream, By Region, 2019-2032 (USD Billion)
- 7.4. Downstream
- 7.4.1. Global Vaccine Contract Manufacturing Market, by Downstream, By Region, 2019-2032 (USD Billion)
8. Global Vaccine Contract Manufacturing Market, by Geography
- 8.1. Key findings
- 8.2. Introduction
- 8.2.1. Vaccine Contract Manufacturing Market Assessment, By Geography, 2019-2032 (USD Billion)
- 8.3. Vaccine Contract Manufacturing Market - North America
- 8.3.1. North America: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
- 8.3.2. North America: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
- 8.3.3. North America: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
- 8.3.4. Vaccine Contract Manufacturing Market - U.S.
- 8.3.4.1. U.S.: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
- 8.3.4.2. U.S.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
- 8.3.4.3. U.S.: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
- 8.3.5. Vaccine Contract Manufacturing Market - Canada
- 8.3.5.1. Canada: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
- 8.3.5.2. Canada.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
- 8.3.5.3. Canada: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
- 8.4. Vaccine Contract Manufacturing Market - Europe
- 8.4.1. Europe: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
- 8.4.2. Europe.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
- 8.4.3. Europe: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
- 8.4.4. Vaccine Contract Manufacturing Market - UK
- 8.4.4.1. UK: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
- 8.4.4.2. UK.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
- 8.4.4.3. UK: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
- 8.4.5. Vaccine Contract Manufacturing Market - France
- 8.4.5.1. France: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
- 8.4.5.2. France.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
- 8.4.5.3. France: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
- 8.4.6. Vaccine Contract Manufacturing Market - Germany
- 8.4.6.1. Germany: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
- 8.4.6.2. Germany.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
- 8.4.6.3. Germany: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
- 8.4.7. Vaccine Contract Manufacturing Market - Italy
- 8.4.7.1. Italy: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
- 8.4.7.2. Italy.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
- 8.4.7.3. Italy: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
- 8.4.8. Vaccine Contract Manufacturing Market - Spain
- 8.4.8.1. Spain: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
- 8.4.8.2. Spain.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
- 8.4.8.3. Spain: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
- 8.4.9. Vaccine Contract Manufacturing Market - Netherlands
- 8.4.9.1. Netherlands: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
- 8.4.9.2. Netherlands.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
- 8.4.9.3. Netherlands: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
- 8.4.10. Vaccine Contract Manufacturing Market - Russia
- 8.4.10.1. Russia: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
- 8.4.10.2. Russia.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
- 8.4.10.3. Russia: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
- 8.5. Vaccine Contract Manufacturing Market - Asia Pacific
- 8.5.1. Asia Pacific: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
- 8.5.2. Asia Pacific.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
- 8.5.3. Asia Pacific: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
- 8.5.4. Vaccine Contract Manufacturing Market - China
- 8.5.4.1. China: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
- 8.5.4.2. China.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
- 8.5.4.3. China: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
- 8.5.5. Vaccine Contract Manufacturing Market - India
- 8.5.5.1. India: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
- 8.5.5.2. India.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
- 8.5.5.3. India: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
- 8.5.6. Vaccine Contract Manufacturing Market - Malaysia
- 8.5.6.1. Malaysia: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
- 8.5.6.2. Malaysia.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
- 8.5.6.3. Malaysia: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
- 8.5.7. Vaccine Contract Manufacturing Market - Japan
- 8.5.7.1. Japan: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
- 8.5.7.2. Japan.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
- 8.5.7.3. Japan: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
- 8.5.8. Vaccine Contract Manufacturing Market - Indonesia
- 8.5.8.1. Indonesia: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
- 8.5.8.2. Indonesia.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
- 8.5.8.3. Indonesia: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
- 8.5.9. Vaccine Contract Manufacturing Market - South Korea
- 8.5.9.1. South Korea: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
- 8.5.9.2. South Korea.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
- 8.5.9.3. South Korea: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
- 8.6. Vaccine Contract Manufacturing Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
- 8.6.2. Middle East & Africa.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
- 8.6.3. Middle East & Africa: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
- 8.6.4. Vaccine Contract Manufacturing Market - Saudi Arabia
- 8.6.4.1. Saudi Arabia: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
- 8.6.4.2. Saudi Arabia.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
- 8.6.4.3. Saudi Arabia: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
- 8.6.5. Vaccine Contract Manufacturing Market - UAE
- 8.6.5.1. UAE: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
- 8.6.5.2. UAE.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
- 8.6.5.3. UAE: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
- 8.6.6. Vaccine Contract Manufacturing Market - Israel
- 8.6.6.1. Israel: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
- 8.6.6.2. Israel.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
- 8.6.6.3. Israel: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
- 8.6.7. Vaccine Contract Manufacturing Market - South Africa
- 8.6.7.1. South Africa: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
- 8.6.7.2. South Africa.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
- 8.6.7.3. South Africa: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
- 8.7. Vaccine Contract Manufacturing Market - Latin America
- 8.7.1. Latin America: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
- 8.7.2. Latin America.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
- 8.7.3. Latin America: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
- 8.7.4. Vaccine Contract Manufacturing Market - Mexico
- 8.7.4.1. Mexico: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
- 8.7.4.2. Mexico.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
- 8.7.4.3. Mexico: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
- 8.7.5. Vaccine Contract Manufacturing Market - Brazil
- 8.7.5.1. Brazil: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
- 8.7.5.2. Brazil.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
- 8.7.5.3. Brazil: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
- 8.7.6. Vaccine Contract Manufacturing Market - Argentina
- 8.7.6.1. Argentina: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
- 8.7.6.2. Argentina.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
- 8.7.6.3. Argentina: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
- 10.1. AGC Biologics
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. Catalent, Inc.
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. Charles River Laboratories
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. Emergent BioSolutions
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. Fujifilm Diosynth Biotechnologies
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. IDT Biologika GmbH
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. KBI Biopharma
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. Lonza Group
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. Merck KGaA
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. Recipharm AB
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
- 10.11. Richter-Helm BioLogics GmbH & Co. KG
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
- 10.12. Seqirus (CSL Limited)
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development
- 10.13. WuXi Biologics
- 10.13.1. Company Overview
- 10.13.2. Financial Performance
- 10.13.3. Product Benchmarking
- 10.13.4. Recent Development
- 10.14. Samsung Biologics
- 10.14.1. Company Overview
- 10.14.2. Financial Performance
- 10.14.3. Product Benchmarking
- 10.14.4. Recent Development
Product Code: PM4069
List of Tables
- Table 1 Global Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
- Table 2 Global Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
- Table 3 Global Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
- Table 4 Vaccine Contract Manufacturing Market Assessment, By Geography, 2019-2032 (USD Billion)
- Table 5 North America: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
- Table 6 North America: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
- Table 7 North America: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
- Table 8 U.S.: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
- Table 9 U.S.: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
- Table 10 U.S.: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
- Table 11 Canada: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
- Table 12 Canada: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
- Table 13 Canada: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
- Table 14 Europe: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
- Table 15 Europe: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
- Table 16 Europe: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
- Table 17 UK: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
- Table 18 UK: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
- Table 19 UK: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
- Table 20 France: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
- Table 21 France: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
- Table 22 France: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
- Table 23 Germany: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
- Table 24 Germany: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
- Table 25 Germany: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
- Table 26 Italy: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
- Table 27 Italy: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
- Table 28 Italy: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
- Table 29 Spain: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
- Table 30 Spain: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
- Table 31 Spain: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
- Table 32 Netherlands: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
- Table 33 Netherlands: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
- Table 34 Netherlands: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
- Table 35 Russia: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
- Table 36 Russia: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
- Table 37 Russia: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
- Table 38 Asia Pacific: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
- Table 39 Asia Pacific: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
- Table 40 Asia Pacific: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
- Table 41 China: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
- Table 42 China: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
- Table 43 China: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
- Table 44 India: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
- Table 45 India: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
- Table 46 India: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
- Table 47 Malaysia: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
- Table 48 Malaysia: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
- Table 49 Malaysia: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
- Table 50 Japan: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
- Table 51 Japan: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
- Table 52 Japan: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
- Table 53 Indonesia: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
- Table 54 Indonesia: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
- Table 55 Indonesia: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
- Table 56 South Korea: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
- Table 57 South Korea: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
- Table 58 South Korea: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
- Table 59 Middle East & Africa: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
- Table 60 Middle East & Africa: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
- Table 61 Middle East & Africa: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
- Table 62 Saudi Arabia: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
- Table 63 Saudi Arabia: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
- Table 64 Saudi Arabia: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
- Table 65 UAE: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
- Table 66 UAE: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
- Table 67 UAE: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
- Table 68 Israel: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
- Table 69 Israel: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
- Table 70 Israel: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
- Table 71 South Africa: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
- Table 72 South Africa: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
- Table 73 South Africa: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
- Table 74 Latin America: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
- Table 75 Latin America: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
- Table 76 Latin America: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
- Table 77 Mexico: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
- Table 78 Mexico: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
- Table 79 Mexico: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
- Table 80 Brazil: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
- Table 81 Brazil: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
- Table 82 Brazil: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
- Table 83 Argentina: Vaccine Contract Manufacturing Market, by Vaccine Type, 2019-2032 (USD Billion)
- Table 84 Argentina: Vaccine Contract Manufacturing Market, by Application, 2019-2032 (USD Billion)
- Table 85 Argentina: Vaccine Contract Manufacturing Market, by Process, 2019-2032 (USD Billion)
List of Figures
- Figure 1. Global Vaccine Contract Manufacturing Market, 2019-2032 (USD Billion)
- Figure 2. Integrated Ecosystem
- Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
- Figure 4. Market by Geography
- Figure 5. Porter's Five Forces
- Figure 6. Market by Application
- Figure 7. Global Vaccine Contract Manufacturing Market, by Application, 2022 & 2032 (USD Billion)
- Figure 8. Market by Vaccine Type
- Figure 9. Global Vaccine Contract Manufacturing Market, by Vaccine Type, 2022 & 2032 (USD Billion)
- Figure 10. Market by Process
- Figure 11. Global Vaccine Contract Manufacturing Market, by Process, 2022 & 2032 (USD Billion)
- Figure 12. Vaccine Contract Manufacturing Market Assessment, By Geography, 2019-2032 (USD Billion)
- Figure 13. Strategic Analysis - Vaccine Contract Manufacturing Market
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.